XNAS · BMRN
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
BioMarin Pharmaceuticals Inc

BioMarin Pharmaceuticals Inc

PHARMACEUTICAL PREPARATIONS
$58.99
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is BMRN moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About BioMarin Pharmaceuticals Inc
PHARMACEUTICAL PREPARATIONS
Listed since
1999
Employees
3K
Country
US

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$58.99
Last session
Day high
$58.99
Last session
Day low
$58.99
Last session
Previous close
$58.99
52W high
$59.27
-0.47% from high
52W low
$54.69
94% of range
Market cap
$11.4B
P/E
23.04×
EPS
$2.56
Shares out
193.3M
VWAP
$58.99
Last session
Price history computed in-house
1W
+0.08%
SMA 50 $56.83 · above
SMA 200 $56.83 · above
52W position 94%
Veridion warehouse edge

Warehouse intelligence for BMRN.

Veridion Score
66
0: 741: 472: 523: 504: 785: Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

BMRN insider activity

BioMarin Pharmaceuticals Inc

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for BMRN.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

BMRN contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BMRN in this window.
Lobbying spend

BMRN lobbying filings, year to date.

Registered lobbying filings matched to BioMarin Pharmaceuticals Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BMRN in this window.
Latest news · BMRN
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for BMRN.
Options
Sovereign unlock shows live options positioning for BMRN.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.